Echopoint Medical Ltd is pleased to announce the appointment of Nancy Briefs as our new Chair of the Board. Nancy brings a wealth of expertise in med-tech innovation and strategic leadership that aligns with our mission to address gender disparities in cardiovascular diagnostics, particularly for INOCA (Ischemia with Non-Obstructive Coronary Arteries).

As we prepare to launch iKOr in the U.S. and undertake clinical trials following FDA market clearance, Nancy’s leadership will be instrumental in supporting our growth and commitment to delivering accessible, patient-focused diagnostic solutions.

Antony Odell, CEO of Echopoint Medical, shared, “Nancy’s dedication to healthcare innovation and deep experience in the med-tech space make her an invaluable addition to our team. Her guidance will be crucial as we expand our impact in cardiovascular diagnostics.”

Nancy also expressed her excitement about the journey ahead: “I’m honored to join Echopoint at this pivotal time. The company’s commitment to addressing gender disparities in cardiovascular health through advanced diagnostics resonates deeply with me. I look forward to working with the team to make a meaningful difference in patient care, especially as we bring iKOr to the U.S. market.”

This marks an important step forward with Nancy’s leadership.